The insider selling is too small to warrant a bearish read. Routine derivative exercises and sales by a CMO and director are common for liquidity and tax planning. Monitor for any upcoming clinical catalysts or earnings news that could provide context, but no immediate action is required.
Price Chart
Executive Summary
Two insiders at Immunome (CMO and a director) sold shares totaling $2.19M in open-market transactions over a 7-day window. The sales represent less than 0.1% of the company's $2.7B market cap, making them routine and non-material. No specific catalyst or pattern suggests informed selling.
Key Financial Metrics
Key Facts
- Total open-market sales of $2.19M by two insiders (CMO Robert Lechleider and Director Isaac Barchas) over a 7-day window ending July 2, 2026.
- Sales represent approximately 0.08% of Immunome's $2.7B market cap, well below the 0.1% materiality threshold.
- CMO Lechleider also exercised 110,000 stock options (55,000 at $0 and 55,000 at $8.73) concurrently with the sales, a common pattern to cover tax obligations or generate liquidity.
Financial Impact
Negligible — less than 0.1% of market cap sold.
Risk Factors
- Insider selling could continue if the stock price appreciates further, but the current level is immaterial.
- Historical model performance on IMNM shows negative drift, but this filing's low score limits downside risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IMNM-1783461710403 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 1d ago | ANALYST-UPGRADE | $21.58 awaiting T+5 | awaiting T+5 | — | $20.97 (−2.85%) |
Sep 21, 2026 11d ago | ANALYST-UPGRADE | $25.07 $21.68 | ▼ −13.52% | ▼ −13.24% | $20.97 (−16.37%) |
Aug 12, 2026 7w ago | Insider Cluster | $26.42 $28.08 | ▲ +6.28% | ▲ +8.25% | $20.97 (−20.65%) |
Aug 10, 2026 7w ago | Insider Cluster | $26.25 $27.56 | ▲ +4.99% | ▲ +5.39% | $20.97 (−20.13%) |
Jul 9, 2026 12w ago | Insider Cluster | $23.35 $22.20 | ▼ −4.93% | ▼ −4.36% | $20.97 (−10.21%) |
Jul 7, 2026 12w ago | Insider Cluster | $24.01 $22.59 | ▼ −5.91% | ▼ −6.78% | $20.97 (−12.68%) |
Jul 7, 2026 12w ago | Insider Cluster | $24.01 $22.59 | ▼ −5.91% | ▼ −6.78% | $20.97 (−12.68%) |
Jul 3, 2026 13w ago | Insider Cluster | $23.61 $24.17 | ▼ −2.37% | ▼ −1.44% | $20.97 (+11.20%) |
May 28, 2026 18w ago | ANALYST-UPGRADE | $22.54 $19.81 | ▼ −12.11% | ▼ −12.06% | $20.97 (−6.99%) |
May 12, 2026 20w ago | 8-K | $22.20 $19.66 | ▼ −11.44% | ▼ −10.28% | $20.97 (−5.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access